PortViewPortView
IMV logo

IMV (IMV) Stock Analysis

NASDAQHealthcareBiotechnology

$0.82+0.00%
1-year price historyRange $0.05 – $9.96
52-week range$0.82
$0.00$10.40

Track IMV in your portfolio for free · Portfolio tracker

What IMV does

IMV Inc., a clinical-stage biotechnology company founded in 2000 and based in Dartmouth, Canada, is focused on immuno-oncology. The firm develops a range of therapeutic candidates for solid and hematological cancers utilizing its proprietary DPX immune-educating technology platform. Its primary drug candidate, maveropepimut-S, is a DPX-based immunotherapy engineered to specifically target survivin-expressing cells. This compound is currently in Phase II clinical trials for several cancer types, including diffuse large B cell lymphoma, ovarian cancer, bladder cancer, liver cancer, and tumors exhibiting high microsatellite instability. Maveropepimut-S is also being investigated in a Phase I clinical trial for breast cancer. The company's pipeline further includes DPX-SurMAGE, which is in Phase I development for bladder cancer, as well as DPX-COVID-19 and DPX-RSV, both aimed at addressing infectious diseases. IMV Inc. was previously known as Immunovaccine Inc. before changing its name in May 2018.

Key metrics

Market cap
$9.63M
P/E (TTM)
-0.18
EPS (TTM)
$-4.55
Beta
1.52
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.55
200-day avg
$2.73
52-week high
$10.40
52-week low
$0.00
CEO
Andrew Hall

ETFs linked to IMV

Broad-market and Healthcare sector ETFs an investor holding IMV is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IMV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IMV in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for IMV?
IMV trades under the ticker IMV on NASDAQ.
Which exchange is IMV listed on?
IMV is listed on NASDAQ.
What sector does IMV operate in?
IMV is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IMV in a portfolio?
PortView shows IMV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.